RemedyRepack Inc. recalls Duloxetine Delayed-Release Capsules
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.
- Products
-
- Duloxetine Delayed-Release Capsules
- Company
- RemedyRepack Inc.
- Where it was sold
-
Nationwide in the US
Nationwide
- Units affected
- a) 1,564 cards, b) 799 bottles
- About this recall
- Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx only, Source NDC 57237-0019-99, MFG: Rising Pharma, Inc., Allendale, NJ, Repackaged by: RemedyRepack Inc., Indiana, PA